Kelcy J. Newell

AstraZeneca (United States)

Papers

1

Total Citations

13

H-Index

1

About

Kelcy J. Newell is a bioprocess engineer whose research centers on advancing virus filtration technologies for biopharmaceutical manufacturing. Her major contribution lies in developing a novel high-throughput screening tool that addresses a critical bottleneck in virus filtration process development. Traditional bench-scale models require large volumes of filter load and costly virus clearance studies, but Newell’s innovative approach enables more efficient throughput testing, reducing resource demands and accelerating the path to commercial production. Her most-cited work, "A novel high-throughput process development screening tool for virus filtration" (2020), has garnered 13 citations, reflecting its growing recognition among peers in the bioprocessing community. This tool directly supports the safe and scalable production of mammalian cell culture-derived biologics, where virus filtration is essential for patient safety. Newell’s work exemplifies how targeted engineering solutions can streamline regulatory-compliant manufacturing, making her a valuable contributor to the field of downstream bioprocessing. Her research continues to impact process development strategies, offering practical pathways to enhance efficiency without compromising safety or quality.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
A novel high-throughput process development screening tool for virus filtration
13 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: AstraZeneca (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago